Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001641172-25-001496
Filing Date
2025-03-31
Accepted
2025-03-31 08:30:35
Documents
83
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 form10-k.htm   iXBRL 10-K 1414539
2 ex23-1.htm EX-23.1 4588
3 ex31-1.htm EX-31.1 12200
4 ex31-2.htm EX-31.2 12890
5 ex31-3.htm EX-31.3 11889
6 ex32-1.htm EX-32.1 13016
7 form10-k_001.jpg GRAPHIC 92102
  Complete submission text file 0001641172-25-001496.txt   6154533

Data Files

Seq Description Document Type Size
8 XBRL SCHEMA FILE cocp-20241231.xsd EX-101.SCH 42141
9 XBRL CALCULATION FILE cocp-20241231_cal.xml EX-101.CAL 64506
10 XBRL DEFINITION FILE cocp-20241231_def.xml EX-101.DEF 163570
11 XBRL LABEL FILE cocp-20241231_lab.xml EX-101.LAB 416404
12 XBRL PRESENTATION FILE cocp-20241231_pre.xml EX-101.PRE 331779
85 EXTRACTED XBRL INSTANCE DOCUMENT form10-k_htm.xml XML 651012
Mailing Address 19805 N. CREEK PARKWAY BOTHELL WA 98011
Business Address 19805 N. CREEK PARKWAY BOTHELL WA 98011 (786) 459-1831
Cocrystal Pharma, Inc. (Filer) CIK: 0001412486 (see all company filings)

EIN.: 352528215 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-38418 | Film No.: 25789068
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)